Analysed RELAY THERAPEUTICS INC (RLAY:NASDAQ) News Sources
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?
06-04-2026
yahoo.com
Relay Therapeutics (RLAY) Is Up 30.6% After Expanding Zovegalisib Into Vascular Anomalies Data Reveal
04-04-2026
yahoo.com
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
02-04-2026
yahoo.com
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.
19-03-2026
fool.com
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
16-03-2026
yahoo.com
Relay Therapeutics (RLAY) Valuation After Breakthrough Therapy Win And Narrower Loss Attracts Fresh Investor Interest
28-02-2026
yahoo.com
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million
27-02-2026
fool.com
What is the current price of RELAY THERAPEUTICS INC (RLAY:NASDAQ)?
The current price of RELAY THERAPEUTICS INC (RLAY:NASDAQ) is $15.39.
RELAY THERAPEUTICS INC (RLAY:NASDAQ) absolute price change since previous trading day?
The absolute price change of RELAY THERAPEUTICS INC (RLAY:NASDAQ) since the previous trading day is $0.45.
RELAY THERAPEUTICS INC (RLAY:NASDAQ) percentage price change since previous trading day?
The percentage price change of RELAY THERAPEUTICS INC (RLAY:NASDAQ) since the previous trading day is 3.012%.
What is the most recent average sentiment score for RELAY THERAPEUTICS INC (RLAY:NASDAQ)?
The most recent average sentiment score for RELAY THERAPEUTICS INC (RLAY:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for RELAY THERAPEUTICS INC (RLAY:NASDAQ)?
The most recent sentiment for RELAY THERAPEUTICS INC (RLAY:NASDAQ) is .
SEC-8K** Filing Available For RELAY THERAPEUTICS INC (RLAY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.